✦ LIBER ✦

Flexibility and function in HIV-1 protease

✍ Scribed by Nicholson, Linda K. ;Yamazaki, Toshimasa ;Torchia, Dennis A. ;Grzesiek, Stephan ;Bax, Ad ;Stahl, Stephen J. ;Kaufman, Joshua D. ;Wingfield, Paul T. ;Lam, Patrick Y.S ;Jadhav, Prabhakar K. ;Hodge, C. Nicholas ;Domaille, Peter J. ;Chang, Chong-Hwan

Book ID: 109964717
Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 728 KB
Volume: 2
Category: Article
ISSN: 1545-9993
DOI: 10.1038/nsb0495-274

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting structural flexibility in HIV-

Targeting structural flexibility in HIV-1 protease inhibitor binding

✍ Viktor Hornak; Carlos Simmerling 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 511 KB

Drug resistance in HIV-1 protease: Flexi

Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations

✍ Stefano Piana; Paolo Carloni; Ursula Rothlisberger 📂 Article 📅 2009 🏛 Cold Spring Harbor Laboratory Press 🌐 English ⚖ 502 KB

Studies on flexibility and binding affin

Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants

✍ Rituraj Purohit; R. Rajasekaran; C. Sudandiradoss; C. George Priya Doss; K. Rama 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 470 KB

The Evolution of Catalytic Function in t

The Evolution of Catalytic Function in the HIV-1 Protease

✍ Manoj Kumar Singh; Kristina Streu; Andrew J. McCrone; Brian N. Dominy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Collective Motions in HIV-1 Reverse Tran

Collective Motions in HIV-1 Reverse Transcriptase: Examination of Flexibility and Enzyme Function

✍ Ivet Bahar; Burak Erman; Robert L. Jernigan; Ali Rana Atilgan; David G. Covell 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 497 KB

HIV-1 protease inhibition potential of f

HIV-1 protease inhibition potential of functionalized polyoxometalates

✍ Andreas Flütsch; Thilo Schroeder; Markus G. Grütter; Greta R. Patzke 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing the